1
|
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse.
|
Ann Oncol
|
2005
|
1.88
|
2
|
High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma.
|
Br J Haematol
|
1999
|
1.84
|
3
|
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.
|
J Clin Oncol
|
2001
|
1.43
|
4
|
Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS.
|
Bone Marrow Transplant
|
1999
|
1.41
|
5
|
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.
|
Ann Oncol
|
2003
|
1.20
|
6
|
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens.
|
Bone Marrow Transplant
|
2001
|
1.10
|
7
|
The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience.
|
Ann Oncol
|
2007
|
1.10
|
8
|
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial.
|
Bone Marrow Transplant
|
2004
|
1.04
|
9
|
Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study.
|
Bone Marrow Transplant
|
2004
|
1.04
|
10
|
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.
|
Br J Haematol
|
2001
|
0.99
|
11
|
Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.
|
J Clin Oncol
|
1998
|
0.96
|
12
|
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.
|
Br J Haematol
|
2001
|
0.91
|
13
|
Iron metabolism and fungal infections in patients with haematological malignancies.
|
J Clin Pathol
|
1995
|
0.90
|
14
|
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation.
|
Bone Marrow Transplant
|
2001
|
0.89
|
15
|
Hematopoietic SCT for peripheral T-cell lymphoma.
|
Bone Marrow Transplant
|
2008
|
0.89
|
16
|
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience.
|
Ann Oncol
|
2004
|
0.87
|
17
|
p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies.
|
Hematol J
|
2001
|
0.86
|
18
|
Characterization of aberrant phenotypes in acute myeloblastic leukemia.
|
Ann Hematol
|
1995
|
0.85
|
19
|
A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique.
|
Cytometry
|
1994
|
0.84
|
20
|
Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant.
|
Bone Marrow Transplant
|
2002
|
0.84
|
21
|
Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.
|
Haematologica
|
2001
|
0.84
|
22
|
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome.
|
Ann Oncol
|
2003
|
0.84
|
23
|
How can we improve problem solving in undergraduate biology? Applying lessons from 30 years of physics education research.
|
CBE Life Sci Educ
|
2013
|
0.83
|
24
|
Rhabdomyolysis associated with septicemia after autologous bone marrow transplantation.
|
Bone Marrow Transplant
|
1997
|
0.82
|
25
|
Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry.
|
Leuk Lymphoma
|
1994
|
0.82
|
26
|
Pathologic rupture of the spleen during induction with ATRA in a patient with acute promyelocytic leukemia.
|
Med Oncol
|
2000
|
0.82
|
27
|
CD34 + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.
|
Leuk Lymphoma
|
2005
|
0.82
|
28
|
Relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation.
|
Eur J Haematol
|
1996
|
0.82
|
29
|
Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
|
Bone Marrow Transplant
|
2001
|
0.81
|
30
|
Immune thrombocytopenic purpura secondary to endometriosis.
|
Haematologica
|
1998
|
0.81
|
31
|
Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia.
|
Leukemia
|
1993
|
0.81
|
32
|
Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease.
|
Haematologica
|
2001
|
0.80
|
33
|
Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics.
|
Blood
|
1988
|
0.79
|
34
|
Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.
|
Br J Cancer
|
1993
|
0.79
|
35
|
Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation.
|
Ann Oncol
|
2010
|
0.79
|
36
|
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
|
Leukemia
|
2000
|
0.78
|
37
|
Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs.
|
Bone Marrow Transplant
|
2010
|
0.78
|
38
|
Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation.
|
Transfusion
|
1998
|
0.78
|
39
|
T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia.
|
Am J Hematol
|
1985
|
0.78
|
40
|
T cells subpopulations in untreated and treated patients with haemophilia A and B.
|
Blut
|
1983
|
0.78
|
41
|
Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation.
|
Bone Marrow Transplant
|
2006
|
0.78
|
42
|
Immunological phenotype of neoplasms involving the B cell in the last step of differentiation.
|
Br J Haematol
|
1986
|
0.77
|
43
|
Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery.
|
Haematologica
|
1999
|
0.77
|
44
|
Phenotypic characterization of skin-infiltrating cells in pagetoid reticulosis by monoclonal antibodies.
|
Acta Derm Venereol
|
1984
|
0.77
|
45
|
[Immune reconstitution after autologous progenitor hemopoietic cell transplantation. A study comparing autologous bone marrow and autologous peripheral blood transplantation].
|
Med Clin (Barc)
|
1998
|
0.76
|
46
|
Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms.
|
Bone Marrow Transplant
|
2010
|
0.76
|
47
|
Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation.
|
Bone Marrow Transplant
|
2000
|
0.76
|
48
|
Factors that influence long-term hematopoietic function following autologous stem cell transplantation.
|
Bone Marrow Transplant
|
1999
|
0.76
|
49
|
Value of colony forming unit-granulocyte macrophage assay in predicting relapse in acute myeloid leukaemia.
|
J Clin Pathol
|
1996
|
0.75
|
50
|
Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study.
|
Bone Marrow Transplant
|
2004
|
0.75
|
51
|
Peculiar cytogenetic finding in T-cell lymphoproliferative disorders.
|
Cancer Genet Cytogenet
|
1985
|
0.75
|
52
|
[Immunologic characterization of hairy-cell leukemia or tricholeukemia].
|
Sangre (Barc)
|
1984
|
0.75
|
53
|
[Guillain-Barr+e syndrome after autologous bone marrow transplantation].
|
Sangre (Barc)
|
1998
|
0.75
|
54
|
[Immunologic and enzymatic markers of acute infantile lymphoblastic leukemias].
|
An Esp Pediatr
|
1984
|
0.75
|
55
|
[Controversies in the determination of CD34].
|
Sangre (Barc)
|
1997
|
0.75
|
56
|
[Immunologic phenotypes of acute lymphoblastic leukemias and their clinico-biological correlations].
|
Sangre (Barc)
|
1984
|
0.75
|
57
|
[Invasive aspergillosis in patients with malignant hemopathies. Usefulness of direct and serologic diagnosis].
|
Sangre (Barc)
|
1993
|
0.75
|
58
|
Clinical and immunological findings in large B-cell chronic lymphocytic leukemia.
|
Clin Immunol Immunopathol
|
1988
|
0.75
|
59
|
[Results of a series of 104 consecutive bilateral bone marrow biopsy specimens in lymphoproliferative disorders].
|
Sangre (Barc)
|
1995
|
0.75
|
60
|
Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease.
|
Neoplasma
|
1985
|
0.75
|
61
|
Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma.
|
Bone Marrow Transplant
|
2004
|
0.75
|
62
|
[Influence of hematopoietic growth factors on transfusion support following autologous bone marrow transplantation].
|
Sangre (Barc)
|
1995
|
0.75
|
63
|
[Monoclonal gammopathies. Progress in differential diagnosis based on immunologic markers].
|
Sangre (Barc)
|
1984
|
0.75
|
64
|
A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation.
|
Br J Haematol
|
1996
|
0.75
|
65
|
An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia.
|
Cytometry
|
1999
|
0.75
|
66
|
[The megakaryoblastic component of mixed blast crises].
|
Sangre (Barc)
|
1985
|
0.75
|
67
|
Bone marrow histopathologic patterns and immunologic phenotype in B-cell chronic lymphocytic leukaemia.
|
Blut
|
1988
|
0.75
|
68
|
Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients.
|
Hematol Cell Ther
|
1997
|
0.75
|
69
|
[Lymphocyte populations in hemophilia A and B. Relation to acquired immunodeficiency syndrome and therapeutic implications].
|
Sangre (Barc)
|
1983
|
0.75
|
70
|
[Cytochemistry of tricholeukemia].
|
Sangre (Barc)
|
1983
|
0.75
|
71
|
[Immunologic phenotype of chronic T lymphatic leukemia].
|
Med Clin (Barc)
|
1984
|
0.75
|
72
|
Complete cytogenetic but not molecular remission in a patient with myeloid blast crisis of chronic myeloid leukemia treated with carboplatin and ara-C.
|
Haematologica
|
1998
|
0.75
|
73
|
Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease.
|
Transfusion
|
2004
|
0.75
|
74
|
Long-term treatment results for acute megakaryoblastic leukaemia patients: a multicentre study.
|
Br J Haematol
|
1992
|
0.75
|
75
|
Immunoblastic lymphoma and associated non-lymphoid malignancies following two cases of Waldenström's macroglobulinemia. A review of the literature.
|
Eur J Haematol
|
1993
|
0.75
|
76
|
Histiocytic cytophagic panniculitis: a rare late complication of allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1994
|
0.75
|
77
|
[The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases].
|
Sangre (Barc)
|
1983
|
0.75
|
78
|
Monocyte counts: an early index of haemopoietic reconstitution after peripheral blood stem cell transplantation.
|
Br J Haematol
|
2000
|
0.75
|